论文部分内容阅读
目的:探讨轻中度溃疡性结肠炎长期维持缓解及抗复发治疗方法及其疗效。方法:通过查阅文献总结各种轻中度溃疡性结肠炎治疗方法及疗效评价。结果:临床上单药(美沙拉嗪)治疗仍是轻中度溃疡性结肠炎长期维持缓解及抗复发的主要手段,微生态制剂主要作为在明确肠道菌群失调的前提下的针对性用药,中医药个体化综合治疗更加经济、安全、有效。结论:美沙拉嗪为治疗轻中度溃疡性结肠炎长期维持缓解及抗复发的首选药物,中医药个体化综合治疗在临床疗效评价及效费比例方面具有客观优势。
Objective: To investigate the long-term maintenance of mild to moderate ulcerative colitis and anti-relapse therapy and its efficacy. Methods: To summarize various treatment methods of mild to moderate ulcerative colitis and evaluate the curative effect through consulting literature. Results: The single drug (mesalazine) treatment is still the main means to maintain long-term relief and anti-relapse in mild to moderate ulcerative colitis. The probiotics are mainly used as the specific drugs under the premise of clear gut flora , Comprehensive treatment of individualized Chinese medicine more economical, safe and effective. Conclusion: Mesalazine is the first choice for the treatment of mild to moderate ulcerative colitis for long-term maintenance of remission and anti-relapse. The individualized comprehensive treatment of traditional Chinese medicine has an objective advantage in clinical efficacy evaluation and cost-effective ratio.